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Abstract: 
Regulation of maturation in meiotically competent mammalian oocytes is a 
complex process involving the carefully coordinated exchange of signals 
between the somatic and germ cell compartments of the ovarian follicle via 
paracrine and cell-cell coupling pathways. This review highlights recent 
advances in our understanding of how such signaling controls both meiotic 
arrest and gonadotropin-triggered meiotic resumption in competent oocytes 
and relates them to the historical context. Emphasis will be on rodent 
systems, where many of these new findings have taken place. A regulatory 
scheme is then proposed that integrates this information into an overall 
framework for meiotic regulation that demonstrates the complex interplay 
between different follicular compartments. 
I. Overview of Oocyte Maturation 
Meiosis is initiated in the mammalian oocyte during fetal 
development but at about the time of birth becomes arrested late in 
prophase I, at the late G2 phase of the cell cycle, and can persist in 
this state for many years. When a cohort of follicles is stimulated to 
initiate development, meiotic arrest is maintained throughout the 
period of oocyte and follicle growth, during which time the oocyte 
achieves competence to undergo meiosis (Fig. 1). Follicle and oocyte 
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development is orchestrated by a bidirectional exchange of signals 
between the germ and somatic cell compartments; paracrine oocyte 
signals direct the differentiation of the mural and cumulus granulosa 
cells and their regulation of germ cell developmental competence 
(Gilchrist and Thompson, 2007; Su et al, 2009). Meiotically competent 
oocytes within Graafian follicles will then resume meiotic maturation in 
response to the preovulatory surge of gonadotropins, a response 
brought about, at least in part, by the generation of a transient spike 
in cAMP levels within the granulosa cells. 
 
Figure 1 Overview of oocyte maturation. The oocyte remains meiotically 
incompetent and in prophase I arrest during the period of follicular and oocyte growth. 
At the time of meiotic resumption the nucleus, or germinal vesicle, breaks down as the 
chromosomes condense and meiosis proceeds until the metaphase II stage that 
immediately follows extrusion of the first polar body. The MII arrest is maintained in 
healthy oocytes until successful fertilization is achieved, whereupon the oocyte 
completes maturation, maternal and paternal chromatin is combined, and embryonic 
development is initiated. 
If oocytes are removed from non-stimulated Graafian follicles 
and placed in a suitable culture medium, they will undergo 
spontaneous, hormone-independent nuclear maturation, indicated by 
germinal vesicle breakdown (GVB), the first easily observed 
manifestation of maturation (Pincus and Enzmann, 1934; Edwards, 
1965). The G2-to-M phase cell cycle progression, which occurs at the 
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time of GVB in oocytes, depends on the activation of maturation 
promoting factor (MPF), a dimer comprised of CDK kinase and cyclin B 
subunits (Norbury and Nurse, 1992). MPF activation leads to a cascade 
of cellular phosphorylation through serine/threonine kinase activity 
(Murray and Kirschner, 1989), driving chromosome condensation and 
dissolution of the nuclear envelope. MPF activity is negatively 
controlled by cAMP through regulation of Wee1 kinases and cdc25 
phosphatases (Han et al, 2005; Han and Conti, 2006; Solc et al, 2008; 
Zhang et al, 2008; Pirino et al, 2009). 
Because of the phenomenon of spontaneous maturation, it is 
evident that the somatic compartment of the ovarian follicle imposes 
an inhibitory constraint upon the oocyte, maintaining it in meiotic 
arrest, and this meiotic arrest can be achieved in vitro in isolated 
oocytes by a number of inhibitory agents, including cAMP analogs, 
purines and phosphodiesterase inhibitors (Schultz, 1986), that block 
the activation of MPF (Choi et al, 1991). However, under these 
inhibitory conditions, addition of gonadotropin or other suitable ligand 
leads to the induction of GVB, but only in oocytes enclosed by 
granulosa cells (Downs et al, 1988). Thus, within the follicle, the 
somatic compartment controls both the maintenance of meiotic arrest 
and induction of meiotic resumption. 
Once GVB has been triggered, the oocyte progresses meiotically 
through metaphase I (MI) and reaches metaphase II (MII), where it 
arrests for a second time. This second arrest point occurs at about the 
time of ovulation and is controlled by the oocyte itself, since by this 
time close association of the somatic and germ cell compartments has 
been eliminated through mucification and expansion of the cumulus 
granulosa cells. No further development is possible unless the oocyte 
is fertilized or activated parthenogenetically. 
This review will focus on aspects of meiotic regulation 
surrounding the prophase I block, including maintenance of meiotic 
arrest and possible mechanisms of meiotic induction. Emphasis will be 
on studies using rodent oocytes, since many recent advances in our 
understanding of meiosis have occurred in these species. Other useful 
reviews on oocyte maturation include Zhang et al, 2009; Hsieh et al, 
2009; Tsafriri and Motola, 2007; Lefevre et al, 2007; Kimura et al, 
2007; Mehlmann, 2005; Tsafriri et al, 2005; Dekel, 2005). 
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II. In Vitro Models for Studying Mammalian 
Oocyte Maturation 
Illustrated in Fig. 2 are three different in vitro models commonly 
utilized to study oocyte maturation. There are pros and cons to each of 
these approaches, but information gleaned from all three has proven 
useful in delineating different aspects of meiotic regulation. The first is 
the most physiological and involves dissecting out intact preovulatory 
follicles. Because the follicle is intact, meiotic arrest is maintained 
naturally in culture without the need for supplementary inhibitors. 
Meiotic resumption can then be stimulated with gonadotropins or other 
agents such as EGF-like peptides. The second model system utilizes 
cumulus cell-enclosed oocytes (CEO) isolated from preovulatory 
follicles. Due to the reduced number of follicle cells, meiosis-inhibitory 
capability is lost, and these oocytes will undergo spontaneous 
maturation in vitro unless a meiotic inhibitor, such as a cAMP analog or 
phosphodiesterase inhibitor, is added to the medium. Under inhibitory 
conditions, meiotic resumption can be induced by gonadotropin or 
other stimulatory ligands. In the last system, the cumulus cells are 
removed to produce denuded oocytes (DO). DO will also undergo 
spontaneous maturation unless meiotic inhibitors are added, but, 
unlike CEO, will not respond to hormonal stimulation due to the 
absence of mediating follicle cells that possess the necessary 
receptors. 
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Figure 2 In vitro model systems for studying oocyte maturation. The intact 
preovulatory follicle (top) maintains the oocyte in the germinal vesicle (GV) stage in 
the absence of hormonal stimulation. The addition of hormone (gonadotropins or EGF-
like peptides) stimulates germinal vesicle breakdown (GVB) after binding to receptors 
on the follicle cells. Arrows show the cells responsive to each of the hormones. 
Removal of the cumulus-enclosed oocyte (CEO) results in spontaneous maturation in 
the absence of added inhibitor. If maintained in meiotic arrest with appropriate 
inhibitor, GVB can be induced by proper hormonal stimulation (FSH and EGF-like 
peptides, but not LH). Removal of cumulus cells produces a denuded oocyte (DO) that 
will also undergo spontaneous maturation, but is unresponsive to hormones if 
maintained in meiotic arrest. 
It is important to understand the limitations of these different 
experimental approaches. While the study of isolated DO and CEO 
enables the examination of direct effects of certain agents on these 
target cells without the confounding influence of additional follicular 
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tissue, the system is not completely physiological. On the other hand, 
it is sometimes difficult when using the more complex cultured follicle 
system or intact animal to identify the specific tissue(s) targeted by a 
particular treatment that mediate a meiotic response. Also, the 
literature is replete with studies demonstrating that the spontaneous 
meiotic maturation occurring when oocytes are removed from the 
follicle and cultured in permissive medium is not under the same 
regulation as oocytes induced to resume maturation by hormonal 
stimulation. Thus, one must be cautious when using the spontaneous 
maturation model, since some of the oocyte behaviors may not 
duplicate those elicited by meiosis-inducing stimuli in the intact follicle. 
III. Maintenance of Meiotic Arrest 
Folliculogenesis involves a close cooperative association 
between the developing germ and somatic cells. Bidirectional signaling 
between these two compartments ensures the proper differentiation of 
each cell type and successful development of the preovulatory follicle. 
This is exemplified by recent studies showing that, under the direction 
of oocyte-secreted factors, the surrounding cumulus granulosa cells 
carry out critical metabolic functions that the oocyte is unable to 
perform (Su et al, 2009). Granulosa cell products can then reach the 
oocyte by paracrine means or by direct transfer between the 
heterologous cells. During follicle growth, the oocyte is intimately 
coupled to the surrounding granulosa cells by gap junctional 
communication, enabling transmission of ions and small molecules 
through these intercellular membrane channels. Connexin (Cx) 
proteins are the fundamental units of gap junctions that provide for 
granulosa-granulosa coupling as well as granulosa-oocyte coupling. 
Cx43 is a major connexin present in gap junctions between somatic 
cells, while Cx37 junctions are restricted to the granulosa-oocyte 
interface (Kidder and Mhawi, 2002; Teilmann, 2005; see Fig. 2). While 
some Cx37 is expressed in granulosa cells away from the oocyte 
interface, homotypic Cx37 junctions exist primarily at this interface 
where they are controlled by the oocyte and mediate coupling between 
the two cell types (Veitch et al, 2004; see Fig. 3). The importance of 
these gap junctional proteins in folliculogenesis has been 
demonstrated by failure of normal development following knockout of 
either connexin in mice, with loss of Cx43 function severely restricting 
folliculogenesis (Juneja et al, 1999), while ablation of Cx37 function 
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prevents both follicular development to the antral stage as well as 
normal oocyte growth and acquisition of meiotic competence (Simon et 
al, 1997; Carabatsos et al, 2000). Cx37 is probably responsible for 
mediating meiotic control in mice, since normal oogenesis occurred 
upon oocyte-targeted depletion of Cx43 (Gershon et al, 2008). 
 
Figure 3 Gap junction regulation of meiotic status. Homologous Cx 43 gap 
junctions couple mural granulosa cells (green) to one another and cumulus granulosa 
cells (blue) to one another, and heterologous gap junctions couple mural granulosa 
cells to cumulus granulosa cells. Heterologous Cx 37 gap junctions in the innermost 
layer of cumulus cells couple the somatic compartment of the follicle to the oocyte. 
Two different models exist for meiotic regulation. In the loss of inhibition model, loss 
of Cx 43 coupling terminates the flux of inhibitor (cAMP and cGMP) from mural to 
cumulus cells, thereby significantly reducing levels within the oocyte and leading to 
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GVB. In the positive stimulation model, patent gap junctions mediate the flux of a 
positive stimulus into the oocyte from the surrounding follicle cells that can override 
elevated cyclic nucleotide levels, although contribution of a diffusible paracrine factor 
(dotted lines) originating from the granulosa cells cannot be discounted. 
cAMP involvement 
cAMP is an important physiological regulator of meiosis that 
maintains meiotic arrest by suppressing MPF activity through 
stimulation of cAMP-dependent protein kinase A (PKA). Many studies 
have confirmed that adenylate cyclase activators, cAMP analogs or 
phosphodiesterase (PDE) inhibitors reversibly suppress GVB and that 
inhibitors or antagonists of PKA can reverse meiotic arrest maintained 
by cAMP-elevating agents (Schultz, 1991). In addition, perturbation of 
PKA activity by knockdown of the type I regulatory subunit promoted 
oocyte maturation (Duncan et al, 2006). Moreover, a decrease in 
oocyte cAMP has been shown to precede GVB (Schultz et al, 1983, 
Vivarelli et al, 1983; Racowsky, 1984; Dekel et al, 1984; Sirard and 
First, 1988). Evidence has shown that stimulation of cAMP production 
in the granulosa cells can drive diffusion of the cyclic nucleotide into 
the oocyte via the gap junctional pathway (Bornslaeger and Schultz, 
1985a; Webb et al, 2002). Consistent with this phenomenon is the 
proposal that granulosa cells maintain the oocyte in prophase I in vivo 
by supplying meiosis-arresting levels of cAMP through this coupling 
pathway (Gilula et al, 1978; Dekel et al, 1981). 
Alternatively, substances may diffuse into the oocyte from the 
extracellular milieu that could impart an inhibitory influence to the 
oocyte, helping to maintain cAMP at meiosis-arresting levels. Once 
such compound is the purine base, hypoxanthine, a weak inhibitor of 
cAMP degradation (Downs et al, 1989) that was originally identified in 
porcine follicular fluid (Downs et al, 1985) and was subsequently 
measured in mouse follicular fluid at levels that maintain meiotic arrest 
(Eppig et al, 1985), though its efficacy is strain-dependent (Griffin et 
al, 2004). However, it is doubtful that hypoxanthine is the primary 
intrafollicular inhibitor responsible for maintaining meiotic arrest in situ 
due to its limited inhibitory potency; in fact, it may be released within 
the follicle as a consequence of follicular hypoxia. Nevertheless, its 
presence within the follicle implies potential participation in the overall 
negative regulation of meiosis, and, consequently, it has often been 
used in culture media to maintain meiotic arrest in vitro. Moreover, its 
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inhibitory potential has been confirmed in numerous mammalian 
species (Downs, 1996). 
The idea that oocyte cAMP derives primarily from the granulosa 
cells was challenged by the finding that treatment of DO with the 
adenylate cyclase stimulator, forskolin, elicits suppression of 
spontaneous maturation in vitro in several rodent species in concert 
with an elevation in oocyte cAMP (Urner et al, 1983; Olsiewski and 
Beers, 1983; Ekholm et al, 1984; Racowsky, 1984, 1985). Though 
denudation of oocytes can leave remnants of the cumulus cells still 
attached to the oocyte (Eppig and Downs, 1984), Bornslaeger and 
Schultz (1985b) showed that enzymatic removal of the zona pellucida 
and most of the somatic cell processes produced an oocyte still 
capable of cAMP generation in response to forskolin, thus confirming 
an oocyte source of cAMP. Further evidence supporting oocyte-derived 
cAMP came from studies showing a transient delay in spontaneous 
maturation upon treatment of oocytes with nonhydrolyzable GTP 
analogs (Downs et al, 1992) or the Gs activator, cholera toxin (Dekel 
and Beers, 1978; Schultz et al, 1983b; Vivarelli et al, 1983; Downs et 
al, 1992), which suggested a G-protein-mediated mechanism, and in 
immunocytochemical localization of adenylate cyclase at the oolemma 
(Kuyt et al, 1988). Moreover, in the intact oocyte-cumulus cell 
complex, elevation of cAMP within the cumulus cells does not always 
lead to equilibration of cyclic nucleotide with the oocyte despite a 
patent coupling pathway (Schultz et al, 1983; Bilodeau et al, 1993). 
Definitive evidence for an oocyte source of cAMP came from a 
study showing that both mouse and rat oocytes express the functional 
AC3 isoform of adenylate cyclase; in addition, mice lacking this 
isoform exhibited compromised meiotic arrest in vivo and accelerated 
spontaneous maturation in vitro (Horner et al, 2003). Using an intact 
mouse follicle system whereby injections could be directed into the 
oocyte, Mehlmann, Jaffe and colleagues showed that meiotic arrest 
could be interrupted by microinjection of antibodies to, or a dominant 
negative form of, Gs, demonstrating the presence of a G-protein-linked 
receptor at the oolemma (Mehlmann et al, 2002; Kalinowski et al, 
2004). Subsequent studies determined that oocyte expression of the 
G-protein coupled receptor, PGR3, is essential for maintaining cAMP 
levels and meiotic arrest (Mehlmann et al, 2004; Hinckley et al, 2005; 
Ledent et al, 2005). GPR3 exhibits constitutive activity that is 
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independent of granulosa cell influence (Freudzon et al, 2005). An 
additional functional receptor, GPR12, was also identified in both rat 
and mouse oocytes (Hinckley et al, 2005), but seems to be important 
only in the rat, since the knockout mouse exhibited no phenotype. 
Maintenance of cyclic nucleotide levels in cells is maintained by 
a balance between synthesis, degradation and release from the cell. 
Major players in determining cyclic nucleotide concentration are the 
cyclic nucleotide phosphodiesterases (PDEs), a diverse group of 
enzymes that hydrolyze the 3′ phosphate bond of cyclic nucleotides. 
For example, in the human genome, twenty-one PDE-encoding genes 
and their corresponding proteins have been identified and 
characterized, with some specific for cAMP, some specific for cGMP, 
and others that recognize both cyclic nucleotides (Conti and Beavo, 
2007). PDEs specific for cAMP show an interesting 
compartmentalization within the mammalian follicle. Milrinone and 
cilostamide, inhibitors of PDE3-specific isoforms, suppress 
spontaneous oocyte maturation in follicle-enclosed rat oocytes, but the 
PDE4-specific inhibitor, rolipram, has little effect even at very high 
concentrations; on the other hand, rolipram alone, but not PDE3 
inhibitors, stimulates GVB in cultured follicles (Tsafriri et al, 1996). 
These results suggested that PDE3 resides in the oocyte, while PDE4 is 
present in the somatic compartment, and this was confirmed by in situ 
hybridization. Similar results have been reported from numerous 
laboratories (eg, Shitsukawa et al, 2001; Jensen et al, 2002; Mayes 
and Sirard, 2002; Nogueira et al, 2003; Thomas et al, 2004; Laforest 
et al, 2005). In 1998, Wiersma et al reported the exciting finding that 
injection of PDE3 inhibitors into superovulated rats and mice prevented 
meiotic resumption without affecting ovulation rate, strongly 
suggesting an essential need for oocyte PDE3 in mediating meiotic 
resumption via cAMP degradation. Indeed, PDE3A activity was shown 
to increase after gonadotropin stimulation prior to GVB (Richard et al, 
2001). An absolute requirement for this PDE isoform was later proven 
when the same lab showed PDE3A-deficient mice were infertile due to 
an inability of the oocytes to resume maturation (Masciarelli et al, 
2004). 
Similar to the results with PDE isoforms, we reported differential 
regulation of PKA isozymes within the germ and somatic cell 
compartments of oocyte-cumulus cell complexes from mice (Downs 
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and Hunzicker-Dunn, 1995). Only the type I regulatory PKA subunit 
was detected in oocytes by photoaffinity labeling of PKA regulatory 
subunits with 8-N3-[32P]cAMP, while both type I and II isoforms were 
identified in cumulus cells. In addition, by the use of site-selective 
analogs of cAMP, that in various combinations can selectively activate 
type I or II PKA, meiotic arrest was shown to be more pronounced in 
type I PKA-stimulated oocytes, while selective activation of type II PKA 
in oocyte-cumulus cell complexes more effectively promoted oocyte 
maturation and cumulus expansion. It was concluded that type I PKA 
in the oocyte mediates meiotic arrest, while type II PKA in the 
granulosa cells mediates maturation of the oocyte-cumulus cell 
complex. Similar conclusions were drawn from studies by Rodriguez et 
al (2002). However, more recent reports have demonstrated the 
presence of both type I and II regulatory PKA isoforms in mouse 
oocytes (Brown et al, 2002; Newhall et al, 2006), and in one of these 
studies (Newhall et al, 2006) a combination of site-selective cAMP 
analogs that preferentially stimulate type II PKA isoforms were 
presented as more potent in maintaining meiotic arrest when 
compared with a combination that selectively activated type I PKA, 
with the conclusion that type II PKA is the more relevant isoform 
performing this function. Nevertheless, this conclusion seems tenuous, 
since only one site-selective pairing was compared, and the dose 
response curves were nearly superimposable. It therefore seems safer 
to propose that activation of either isoform in the oocyte can suppress 
GVB. 
Subcellular compartmentalization of PKA isozymes within the 
oocyte is facilitated by A-kinase anchoring proteins (AKAPs). AKAPs 
serve as scaffolding proteins that bind to PKAs and regulate their 
cellular localization, forming microdomains of phosphorylation 
signaling (Wong and Scott, 2004; Smith et al, 2006). AKAPs have 
been identified in rodent oocytes, and their localization is 
developmentally regulated (Brown et al, 2002; Kovo et al, 2002; 
Newhall et al, 2006; Webb et al, 2008). More significantly, disruption 
of AKAP-mediated anchoring of PKA by treatment with peptide 
inhibitors reverses meiotic arrest maintained by PDE inhibitor (Dekel, 
2005; Newhall et al, 2006), demonstrating a vital role for AKAPs in 
meiotic arrest. However, AKAP1-null oocytes are more sensitive to the 
meiosis-arresting action of cAMP-elevating agents than wild type 
oocytes (Newhall et al, 2006), signifying the involvement of multiple 
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AKAPs in meiotic regulation. Controlling PKA localization within the 
oocyte via AKAPs might help explain how meiotic resumption can be 
induced in the presence of elevated cAMP. 
Control of MPF activity 
Ample pre-MPF (Cdk1 and cyclin B) exists in the meiotically 
competent mouse oocyte, and its activity is controlled by the 
phosphorylation state of Cdk1. Sustained levels of cAMP in the mouse 
oocyte persistently activate PKA, promoting phosphorylations that 
positively regulate Wee1 kinase (Han et al, 2005), and negatively 
regulate Cdc25B phosphatase (Lincoln et al, 2005; Pirino et al, 2009). 
These PKA substrates control MPF activity at two highly conserved 
phosphorylation sites (Thr14 and Tyr15) on the Cdk1 kinase of MPF; 
phosphorylation by the Wee1 family of kinases (Wee 1B and Myt1) 
inactivates the kinase, while dephosphorylation by the Cdc25 family, 
most notably Cdc25B, promotes activation (Fig. 4A). Thus, the control 
of MPF by PKA is indirect, brought about by phosphorylation of 
mediating proteins. 
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Figure 4 Regulation of MPF activity in the mouse oocyte. A, Control of MPF by PKA. 
MPF activity is regulated by the phosphorylation state of the Cdk1 subunit. PKA 
activity is dependent on cAMP levels. This cyclic nucleotide binds to the regulatory 
subunit (PKAR), driving dissociation from, and activation of, the catalytic subunit 
(PKAC; asterisk denotes activated state). When sufficient cyclin B is present, MPF is 
maintained in the inactive state by the action of Wee1 and Myt1 kinases that are 
positively regulated by PKA. Dephosphorylation of Cdk1 triggers activation of MPF and 
is principally driven by Cdc25B that is negatively regulated by PKA. This response 
occurs when PKA activity is lowered by a decrease in cAMP, brought about by the 
action of PDE3. Increased PDE3 activity results from a drop in cGMP levels or active 
stimulation by Akt or perhaps PKA. B, Effect of Myt1/Wee1/Cdc25B localization on MPF 
activity. In the competent oocyte, pre-MPF accumulates in the nucleus. Under meiosis-
arresting conditions, Wee1B is present in the germinal vesicle, but Myt1 and Cdc25B 
are restricted to the cytoplasm, and this is under PKA control. When oocyte cAMP 
levels are reduced, Wee1B exits the nucleus and Cdc25B translocates into the nucleus. 
The loss of inhibitory Wee1B and the entry of stimulatory Cdc25B promotes 
dephosphorylation of pre-MPF in the germinal vesicle and its subsequent activation 
that will drive GVB. 
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Localization of these regulatory proteins within the mouse 
oocyte plays a vital role in controlling MPF activity. During the 
development of meiotic competence in mouse oocytes, the 
components of MPF, Cdk1 and cyclin B, accumulate in the nucleus, 
where they will direct meiotic resumption (Mitra and Schultz, 1996). 
Indeed, meiotic regulation is significantly affected by the nuclear 
abundance of cyclin B (Marangos and Carroll, 2004). Zhang et al 
(2008) showed that phosphorylation of Cdc25B by PKA sequesters it in 
the cytoplasm, while a decrease in oocyte cAMP that drives 
inactivation of PKA leads to translocation of Cdc25B from the 
cytoplasm into the nucleus, activation of MPF and meiotic resumption 
(Fig. 4B). A recent study by Oh et al, (2010) confirms this mechanism 
and further clarifies contributions from Wee1B and Myt1 kinases. In 
the prophase I-arrested mouse oocyte, Wee1B is confined to the 
nucleus, while Myt1 and Cdc25B are present only in the cytoplasm. 
Under conditions that permit meiotic resumption, prior to germinal 
vesicle breakdown Cdc25B initially translocates to the nucleus, 
subsequently followed by the exodus of a significant fraction of Wee1B 
from the nucleus into the cytoplasm. The localization of Myt1 is not 
affected before meiotic resumption (Fig. 4B). All three components are 
required for optimal regulation of MPF activity, and it appears that 
removal from the nucleus of the inhibitory kinase combined with entry 
of the stimulatory phosphatase converts pre-MPF to active meiotic 
inducer (Oh et al, 2010; Fig. 3B). A similar role for cdc25C has been 
reported in human oocytes (Cunat et al, 2008). 
Additional MPF regulation exists at the level of the anaphase-
promoting complex (APC). Destruction of cyclin B inactivates MPF and 
requires polyubiquitination by the APC that targets it for proteosomal 
degradation (Murray, 2004). Reis et al (2006) demonstrated that 
cyclin B levels in mouse oocytes are restricted by the activity of APC 
that is maintained by the activator, cdh1. Germinal vesicle-stage 
oocytes contain active APC that is down-regulated by cdh1-targeted 
morpholinos, leading to reduced cyclin B degradation and promotion of 
meiotic resumption in milrinone-arrested oocytes. Further evidence for 
APC mediation of meiotic arrest was provided by Marangos et al 
(2007), who showed that depletion of the APC inhibitor, Emi1, delays 
entry of mouse oocytes into meiosis I and that microinjection of Emi1 
accelerated meiotic resumption. In addition, inhibition of proteosome 
activity induces GVB in hypoxanthine-arrested mouse oocytes in vitro 
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(Huo et al, 2004). Evidence also indicates that APC regulates 
reinitiation of meiosis in pig oocytes (Yamamuro et al, 2008). 
cGMP involvement 
Because the predominant PDE in oocytes controlling cAMP levels 
is cGMP-regulated PDE3A (Shitsukawa et al, 2001), a primary 
candidate for the physiological modulator of PDE3A activity is cGMP. 
This cyclic nucleotide has a myriad of functions in the mammalian 
ovary (reviewed by LaPolt et al, 2003). About three decades ago it was 
shown that ovarian cGMP levels decline significantly in rat (Ratner, 
1976; Ratner and Sanborn, 1980) and hamster (Makris and Ryan, 
1978; Hubbard, 1980) ovaries following LH stimulation. In addition, an 
inverse relationship exists between cAMP and cGMP levels (Hubbard, 
1980). Exposure of hamster oocytes to the cGMP analog, 8-Br-cGMP, 
proved inhibitory to spontaneous maturation in cumulus cell-enclosed 
oocytes (CEO) but not denuded oocytes (DO), and this effect was 
reversed by LH treatment (Hubbard and Terranova, 1980). The 
authors raised several important points regarding a potential role for 
cGMP in meiotic regulation: (1) general PDE inhibitors such as IBMX 
may suppress maturation by their action on cGMP as well as cAMP; (2) 
cGMP action depends on the cumulus cells and may involve alterations 
in cell-cell coupling; and (3) LH may trigger meiosis reinitiation by 
lowering somatic cell cGMP levels. 
A role for cGMP was further supported by work from other 
laboratories that demonstrated an inhibitory effect of cGMP analogs 
and cGMP PDE-specific inhibitors on oocyte maturation in several 
mammalian species (Downs et al, 1988; Tornell et al, 1991; Zhang et 
al, 2005; Wang et al, 2008) and a drop in oocyte cGMP levels prior to 
GVB (Tornell et al, 1990). In addition, blocking the flow of purine 
metabolism to guanyl compounds at the inosine monophosphate 
branchpoint with IMP dehydrogenase inhibitors, which would prevent 
the formation of GTP and, presumably, cGMP, induces meiotic 
resumption in mouse oocytes both in vivo (Downs and Eppig, 1997) 
and in vitro (Downs et al, 1986; Downs, 1990). The fact that these 
inhibitors trigger GVB in CEO but not DO is consistent with the idea 
that guanyl compounds such as cGMP are produced in the somatic 
compartment and then diffuse to the oocyte to contribute to meiotic 
arrest. Indeed, treatment of rat follicles with an inhibitor of soluble 
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guanylate cyclase triggers GVB (Sela-Abramovich et al, 2008). Two 
important modifiers of guanylate cyclase are nitric oxide (soluble form; 
Denninger et al, 1999) and atrial natriuretic peptide (membrane-bound 
form; Waldman and Murad, 1989), and a vast literature indicates that 
each may play an important role in modulating oocyte cGMP levels and 
meiotic arrest (reviewed by Zhang et al, 2007). 
Two recent papers have solidified the importance of cGMP in 
meiotic regulation in mouse oocytes. In the first, Norris et al (2009), 
using FRET-based cyclic nucleotide sensors, provided convincing 
evidence that oocyte cAMP levels are maintained by granulosa cell 
cGMP that is transmitted through gap junctions to suppress oocyte 
PDE3A activity; further, follicular LH stimulation suppresses cGMP 
production by the granulosa cells, leading to a decrease in oocyte 
cGMP and meiotic resumption. In the second study, Vaccari et al 
(2009) report a number of important findings: (1) the cGMP-specific 
PDE, PDE5, is preferentially expressed in the granulosa compartment; 
(2) cGMP suppresses cAMP hydrolysis in oocyte extracts; (3) LH 
stimulation of cultured follicles leads to reduced oocyte cGMP before 
GVB that requires mediation by EGF-like peptides (see below) and is 
prevented by PDE5 inhibitors; and (4) microinjection of cGMP-specific 
PDE into oocytes overcomes meiotic arrest in PDE3A-dependent 
fashion. These data therefore provide convincing evidence that meiotic 
arrest depends, at least in part, on cGMP supplied by the granulosa 
compartment that reaches the oocyte through gap junctions to restrict 
PDE3A activity and maintain elevated oocyte cAMP. 
IV. Mechanisms of Meiotic Induction 
cAMP plays an important role in maintaining the prophase I 
arrest in oocytes, but this cyclic nucleotide has a dual role in meiotic 
regulation, since it also mediates the meiosis-inducing action of 
gonadotropin in granulosa cells. Dekel (1988) proposed an explanation 
for such a paradox in that maturation is blocked when oocyte cAMP is 
maintained above an inhibitory threshold but that meiotic resumption 
results from a transient pulse of elevated cAMP within the granulosa 
cells. Indeed, transient pulsing of follicles or CEOs with cAMP analogs 
or cAMP-elevating agents triggers meiotic resumption (Tsafriri et al, 
1972; Hillensjo et al, 1978; Dekel et al, 1981; Downs et al, 1988). 
Although it has been known for many years that the preovulatory 
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surge of gonadotropins is the initial stimulus for meiotic resumption in 
vivo (Lindner et al, 1974; Tsafriri et al, 1982), only recently have 
some of the downstream transduction pathways mediating 
gonadotropin action been uncovered. 
Mitogen-Activated Protein Kinase 
Mitogen-activated protein kinase (MAPK), known also as 
extracellular-regulated kinase (ERK), comprises a family of Ser/Thr 
kinases that are optimally activated upon phosphorylation on threonine 
and tyrosine residues (Seger and Krebs, 1995; Chen et al, 2001). They 
are turned on by phosphorylation signal cascades initiated by a 
panoply of external signals and transduction pathways. Two isoforms 
are expressed in mammalian oocytes, ERK1 and ERK2, that are 
actively engaged in meiotic regulation. Activity is controlled by the 
upstream kinase, MEK, which, in turn, is regulated further upstream in 
vertebrate oocytes by the MEK kinase, MOS, a product of the cmos 
protooncogene (Sagata et al, 1988). On the other hand, somatic cell 
MEK is regulated by Raf isoforms (Chen et al, 2001). 
Perturbation of these two upstream regulatory sites has 
profound effects on meiotic progression that implicate ERK1/2 in the 
mechanisms regulating oocyte maturation. Because upstream 
regulation of ERKs by MOS is unique to the oocyte, eliminating MOS by 
knockout or other means prevents activation of ERK specifically in the 
germ cell, thereby allowing analysis of germ cell-specific functions. In 
oocytes from Mos knockout mice, meiotic maturation progresses 
normally but oocytes fail to block in MII, demonstrating an essential 
role for ERKs in mediating this second check point (Colledge et al, 
1994; Hashimoto et al, 1994). ERK activity is unaltered and MPF 
fluctuates normally during maturation up until MII, when MPF activity 
drops prematurely (Araki et al, 1996; Choi et al, 1996; Verlhac et al, 
1996). 
Important tools that have emerged for elucidating ERK 
participation in oocyte maturation are the MEK inhibitors, PD98059 
and U0126 (Alessi et al, 1995; Dudley et al, 1995; Favata et al, 1998; 
Davies et al, 2000). These agents have been shown to prevent ERK 
stimulation and meiotic induction in isolated mouse cumulus cell-
enclosed oocytes (Leonardsen et al, 2000; Su et al, 2001, 2002) or 
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follicles (Su et al, 2003). Similar results were obtained in the rat (Sela-
Abramovich et al, 2005; Motola et al, 2008) and numerous non-rodent 
mammalian species (reviewed by Fan and Sun, 2004); yet these 
inhibitors have little effect on spontaneous maturation (Fan et al, 
2003; Tong et al, 2003). 
Oocyte ERK1/2 activity is not required for GVB in rodent 
oocytes, since activity increases only after GVB, whether maturation 
occurs spontaneously (Verlhac et al, 1993; Lu et al, 2001; Tan et al, 
2001) or is hormonally-induced (Su et al, 2002; Sela-Abramovich et 
al, 2005). This relationship is not as clear in domestic species, since 
ERK1/2 is activated prior to GVB in spontaneously maturing equine, 
porcine and bovine oocytes (Fissore et al, 1996; Goudet et al, 1998; 
Inoue et al, 1998). That ERK activity within the rodent oocyte is not 
necessary for meiotic resumption is supported by the finding that in 
mouse oocytes lacking MOS, FSH-induced maturation in hypoxanthine-
arrested cumulus cell-enclosed oocytes was not compromised; 
nevertheless, U0126 suppressed meiotic induction in granulosa cell-
coupled oocytes (Su et al, 2002). These results suggest that 
cumulus/mural granulosa cell ERK is necessary for the in vitro 
induction of maturation by agents acting through the somatic 
compartment. Consistent with this is the finding that cumulus cell 
ERK1/2 activation, as assessed by western analysis of its 
phosphorylation status, precedes GVB in meiotically induced oocytes 
(Su et al, 2002). However, in the mouse, oocyte paracrine signaling is 
absolutely required for the cumulus cell ERK1/2 response and meiotic 
induction, demonstrating that the oocyte plays a crucial role in 
regulating its own meiotic maturation (Su et al, 2003). 
Until recently, the conclusion that granulosa cell ERK stimulation 
mediated hormone-induced oocyte maturation was based primarily on 
two important criteria: (1) granulosa cell ERK activity increased prior 
to GVB and (2) MEK inhibitors suppressed both this activity and 
meiotic resumption. Although PD98059 and U0126 are relatively 
specific kinase inhibitors (Davies et al, 2000; Bain et al, 2007), a 
question of specificity in mouse oocytes was recently raised. Both MEK 
inhibitors prevented meiotic induction in cumulus-free mouse oocytes 
induced to resume maturation even though such induction was not 
mediated by an increase in ERK1/2 activity; the inhibitors were equally 
effective in similarly treated Mos−/− oocytes (LaRosa and Downs, 
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2005). This study, therefore, demonstrated a direct inhibitory effect of 
MEK inhibitors on the oocyte by means unrelated to ERK1/2 activation 
and rendered somewhat tenuous earlier conclusions drawn concerning 
ERK1/2 involvement in meiotic induction. 
However, a new study by JoAnne Richards’ lab (Fan et al, 2009) 
has put to rest any doubt regarding the importance of ERK1/2 in 
meiotic induction. Since two isoforms of ERK exist in the oocyte, 
knocking out both was essential to determine unequivocally whether 
the kinase is required for meiotic induction. And since Erk2-null mice 
are embryonic lethal (Aouadi et al, 2006), ERK2 function could not be 
eliminated at the organism level. The authors accomplished the double 
knockout through conditional ablation of ERK2 function in granulosa 
cells by crossing Erk2fl/fl mice with Cyp19-Cre transgenic mice, which 
knocks out ERK2 activity in granulosa cells, and then crossing these F1 
mice into the Erk1−/− background. Activation of ERK1/2 in the 
granulosa cells that normally occurs following LH stimulation was 
thereby completely eliminated, and, as a consequence, a myriad of 
post-LH ovulatory follicular responses was prevented, including meiotic 
resumption, cumulus expansion, ovulation and luteinization, while 
FSH-dependent effects on follicle growth were extended (Fan et al, 
2009). These results show the critical role Erk1/2 plays in the 
preovulatory response to LH, but, most relevant to this review, 
demonstrate the absolute requirement for Erk1/2 in meiotic induction, 
at least in the mouse. 
EGF-like peptides 
In 1985, Dekel and Sherizly demonstrated stimulation of GVB in 
cultured rat preovulatory follicles by epidermal growth factor (EGF), 
and a similar action in cultured mouse CEOs was confirmed three years 
later (Downs et al, 1988). Moreover, EGF proved to be the most potent 
of ten growth factors tested for stimulation of meiotic induction and 
cumulus expansion (Downs, 1989). In the next several years, studies 
by Roy and Greenwald (1990; 1991a,b) suggested a link between 
gonadotropin stimulation of granulosa cells and EGF-mediated events: 
(1) FSH-stimulated DNA synthesis was mimicked by cAMP and EGF; 
(2) FSH triggered EGF synthesis; and (3) FSH-stimulated DNA 
synthesis was blocked by EGF antiserum. Numerous labs subsequently 
demonstrated a meiosis-inducing action by members of the EGF 
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growth factor family (eg, Brucker et al, 1991; Das et al, 1992; Goud et 
al, 1998;Tsafriri et al, 1989; Prochazka et al, 2000), but more than a 
decade passed before expression of EGF-like peptides by mural and 
cumulus granulosa cells in response to gonadotropin stimulation was 
reported (Espey and Richards, 2002; Sekiguchi et al, 2004; Park et al, 
2004; Ashkenazi et al, 2005; Ben-Ami et al, 2006). 
A seminal study by Conti and colleagues (Park et al, 2004) 
determined that the preovulatory actions of LH are, indeed, mediated 
by members of the EGF growth factor family--not by EGF, but by 
amphiregulin and epiregulin, and, to a lesser extent beta-cellulin. This 
study also showed that these peptides act through the granulosa cells, 
where they bind to the EGF receptor (Shimada et al, 2006). 
Subsequent studies confirmed the potent meiosis-inducing action of 
these EGF-like peptides on the somatic compartment to stimulate GVB 
(reviewed by Hsieh et al, 2009) and that knockout of EGF-like peptides 
in mice compromised meiotic resumption (Hsieh et al, 2007). In 
addition, it appears that protein kinase C (PKC) mediates, at least in 
part, the increase in EGF-like peptides in cumulus granulosa cells in 
response to gonadotropin stimulation (Downs and Chen, 2008; Chen 
et al, 2008), consistent with a stimulatory action of PKC activators on 
meiotic resumption (reviewed by Downs et al, 2001). Romero and 
Smitz (2009) recently reported that optimal induction of meiotic 
resumption in cultured mouse follicles by epiregulin required hCG, but 
these experiments were conducted in follicles grown in vitro that were 
not exposed to hormonal priming in vivo, which may affect their 
responsiveness (cf, Fujinaga et al, 1994). 
Shimada et al (2006) carried out an extensive analysis of the 
dynamics of EGF-like peptides during the preovulatory period and 
proposed an elaborate signaling cascade in which EGF-like peptides 
and prostaglandin E2 provide paracrine communication between the 
mural and cumulus granulosa cells as well as autocrine stimulation 
among each individual granulosa cell sub-type. Gonadotropin or mural 
granulosa-derived PGE2 elicits expression of EGF-like peptides in the 
cumulus mass by a p38MAPK-dependent process that act in autocrine 
fashion to trigger ERK1/2-dependent gene transcription. These gene 
products then mediate the actions of gonadotropins on oocyte 
maturation, cumulus expansion and ovulation (Shimada et al, 2006; 
Conti et al, 2006). 
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Gap junction regulation 
The gap junctional coupling pathway is an important conduit 
through which regulatory molecules are exchanged between the 
follicular somatic and germ cell compartments, and this interface 
between cumulus cells and the oocyte is intimately linked to meiotic 
regulation (Carabatsos et al, 2000). While it is generally agreed that 
this coupling pathway plays a critical role in maintaining meiotic arrest, 
there is less of a consensus on how gap junction dynamics relate to 
meiotic resumption. More than thirty years ago, the attractive 
hypothesis was proffered that gonadotropin stimulation terminated 
coupling between the oocyte and granulosa cell compartments, 
thereby preventing the transfer of inhibitory molecules (eg, cAMP) to 
the oocyte and triggering GVB (Gilula et al,1978; Dekel and Beers, 
1978). Since that time, considerable evidence has been generated to 
support this idea. Ultrastructural studies revealed that significant 
alteration of gap junctions occurred at the time of GVB (Larsen et al, 
1986, 1987) or commitment to undergo GVB (Racowsky et al, 1989; 
Wert and Larsen, 1990). Racowsky and Baldwin (1989) showed that 
when the cumulus cell-enclosed oocyte was physically separated from 
the mural granulosa cell wall in the intact hamster preovulatory follicle, 
meiotic arrest was compromised. GVB can also be initiated by chemical 
interruption of the coupling pathway in rat follicles (Piontkewitz and 
Dekel, 1993; Sela-Abramovich et al, 2006) or arrested mouse CEOs 
(Downs, 2001). Furthermore, gonadotropin stimulation causes a rapid 
phosphorylation of Cx43 (Lau et al, 1992; Granot and Dekel, 1994; 
Shimada et al, 2001; Kalma et al, 2004; Sela-Abramovich et al, 2005, 
2006) that is associated with gap junction closure and appears to be 
dependent on EGF-like peptides (Lau et al, 1992; Leithe and Rivedal, 
2004). 
A critical issue regarding gap junction involvement in meiotic 
regulation, in addition to when, is where the uncoupling occurs. There 
are two likely sites where uncoupling could elicit a meiotic response: 
the mural/cumulus granulosa interface and the cumulus/oocyte 
interface (See Fig. 4). Although several studies have shown a decrease 
in metabolic or dye coupling between the oocyte and cumulus cells at 
the time of GVB, others showed that the coupling does not significantly 
decline prior to GVB (reviewed by Downs, 1995). Furthermore, 
coupling inhibitors can block the meiosis-promoting action of 
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gonadotropin (Fagbohun and Downs, 1991; Coskun and Lin, 1994; 
Downs, 2001) or cumulus cells Vozzi et al, 2001) in isolated CEOs, 
indicating a need for patent gap junctions in meiotic induction. 
However, since in the latter model system the oocyte is not coupled to 
the mural granulosa component of the follicle and requires inhibitory 
agents to maintain meiotic arrest, it may not accurately reflect 
conditions in situ. Furthermore, uncoupling the cumulus mass from the 
mural granulosa could bring about GVB by terminating the flow of 
inhibitory molecules to the oocyte despite extant communication with 
the cumulus cells (Larsen et al, 1987). 
With this question in mind, Norris et al, (2008) examined gap 
junction closure in cultured mouse follicles, using two-photon 
microscopy to monitor diffusion of a microinjected gap junction 
permeant tracer. They reported that, following LH exposure, gap 
junction permeability within the mural granulosa decreased prior to 
GVB in association with ERK1/2-dependent phosphorylation of Cx43, 
but the oocyte was not uncoupled from the cumulus mass before 
meiotic resumption. Antibody to Cx43 and gap junction inhibitor both 
blocked coupling and stimulated GVB. Thus, the data support the 
conclusion that LH triggers GVB in the follicle by sequestering the 
oocyte-cumulus cell mass from the rest of the follicle, thereby 
preventing gap junction-mediated inhibitory input from the mural 
granulosa cells such as cGMP (Norris et al, 2008, 2009). Nevertheless, 
although the data convincingly support such a mechanism, they do not 
prove it is the primary means by which LH works in this capacity in 
vivo. Indeed, treatment of LH-stimulated follicles with a low dose of 
the ERK1/2 inhibitor, U0126, prevented gap junction closure but had 
no effect on meiotic induction (Norris et al, 2008). This supports the 
alternative possibility that a positive stimulus mediates hormone-
induced maturation as opposed to simply isolating the oocyte from the 
somatic compartment (cf, Downs et al, 1988). Recent evidence from 
the porcine system also suggests that meiotic resumption does not 
result simply from loss of gap junctional communication (Sasseville et 
al, 2009). 
The mural/cumulus isolation mechanism also fails to take into 
account the role of EGF-like peptides in meiotic resumption. The rapid 
expression of these peptides following gonadotropin stimulation and 
their potent meiosis-inducing action on the cumulus-enclosed oocyte 
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are commensurate with a paracrine action of mural granulosa-derived 
peptides that diffuse to the CEO and stimulate GVB and cumulus 
expansion (Shimada et al, 2006; Panigone et al, 2008). ERK1/2 
appears to mediate actions of the EGF-like peptides but to also have 
functions upstream of EGFR activation. Preventing activation of EGFR 
blocks--but only partially--ERK1/2 activation, yet meiotic induction in 
mouse follicles is prevented (Panigone et al, 2008). Thus, under these 
conditions, coupling between the cumulus and mural granulosa 
compartments may be abolished (cf, Norris et al, 2008), but meiotic 
induction cannot occur in the absence of EGFR activation. Hence, 
although the oocyte may be isolated from a major source of inhibitory 
input (eg, cGMP), this may not be the sole mechanism regulating 
meiotic resumption; rather, a positive stimulus for maturation 
triggered by EGF-like peptides in the CEO is implicated (Fig. 4). 
Propagating the signal from cumulus to oocyte 
At this time, the nature of the putative positive signal is very 
much a matter of conjecture. Numerous laboratories have investigated 
the possibility of a diffusible meiotic inducer of granulosa origin by 
coculturing meiotically arrested oocytes with granulosa cells under a 
variety of conditions. Studies have shown that cocultured cells can 
alter the medium in such a way that DO are stimulated to resume 
maturation; this has been interpreted as due to active secretion of a 
diffusible factor that can act on the oocyte to trigger a meiotic 
response (reviewed by Downs et al, 2006). But we have been unable 
to consistently demonstrate this effect to a degree that would support 
such a mechanism in vivo. Confounding interpretation are several 
caveats inherent in these types of experiments that include the use of 
small medium volumes, oil overlays, and oocytes denuded of their 
granulosa cell investment. In some instances, the positive coculture 
effect observed may be explained by somatic cell-mediated alterations 
in the levels of culture medium components such as energy substrates 
and meiotic inhibitors like hypoxanthine (Downs et al, 2006). It should 
be noted, however, that the transzonal cumulus cell processes that 
traverse the zona pellucida to make contact with the oolemma are 
ideally suited for depositing secreted products in close proximity to the 
oocyte, which would make possible oocyte exposure to high 
concentrations of a paracrine factor at these focal points (Albertini et 
al, 2001). Such a mechanism is difficult to test experimentally. 
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One type of paracrine factor that has garnered considerable 
scrutiny in the last decade are two closely related sterols, termed 
meiosis-activating sterol (MAS), derived from follicular fluid and bull 
testicular tissue, that were shown to stimulate meiotic resumption in 
hypoxanthine-arrested mouse oocytes (Byskov et al, 1995). Since 
then, many studies have confirmed a meiosis-inducing action in a 
variety of species and have reported other beneficial effects on 
development; nevertheless, the accumulated data have failed to 
identify MAS as an obligatory mediator of meiotic resumption, and its 
role in this capacity has been seriously challenged (Tsafriri et al, 
2005). Steroids are a second type of paracrine factor suggested as a 
meiosis-inducing agent within the follicle. Despite earlier reports to the 
contrary, a recent reexamination of this question has generated data 
supporting a meiosis-inducing action of androgens on arrested mouse 
oocytes in vitro (reviewed by Deng et al, 2009). However we have 
been unable to duplicate these results in the mouse (Downs, 
unpublished), and Tsafriri and colleagues have been unsuccessful in 
rats, leading to the conclusion that these compounds are not 
obligatory mediators of meiotic induction in vivo (Tsafriri and Motola, 
2007). Although androgens can induce meiosis in fish and frogs and 
certain mammalian species, particularly the pig, Li et al (2009) 
speculate that throughout evolution androgens have become 
increasingly less important for this function and have been replaced by 
gonadotropins. 
As mentioned earlier, numerous studies using chemical gap 
junctional blockers have implicated this coupling pathway in the 
hormone induction within CEO in vitro. Nevertheless, the chemical 
nature of the putative positive agent that can traverse the cumulus-
oocyte gap junctions remains enigmatic. One appealing candidate, 
calcium, can induce meiotic resumption (Homa et al, 1993), and 
calcium or a calcium-releasing agent has been shown to cross these 
gap junctions (Mattioli et al, 1998; Webb et al, 2002). Evidence is 
strongest in the spontaneously maturing mouse oocyte model, where 
the involvement of PKC and the PI3 kinase signaling pathway have 
been implicated (Lefevre et al, 2007). However, calcium does not 
appear to be the agent responsible for transducing the maturation 
signal generated by gonadotropin stimulation (Webb et al, 2002b; 
Mehlmann et al, 2006). Clearly, if gap junction-mediated transfer of a 
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positive stimulus is important for meiotic induction, the agent in 
question needs to be identified. 
Whatever the positive signal received by the mouse oocyte, 
cGMP-sensitive PDE3A likely mediates its action. The drop in oocyte 
cGMP that occurs prior to GVB would release an inhibition on the 
enzyme, increasing its activity. But it has also been shown that protein 
kinase B/Akt stimulates meiotic resumption in mouse oocytes in a 
PDE3A-dependent manner (Han et al, 2006). Thus, the putative 
positive signal may act by turning on the PI3 transduction pathway, 
activating Akt and PDE3A, and thereby driving GVB. It is possible that 
a fall in cGMP acts cooperatively with Akt activation to rapidly trigger 
cAMP degradation. 
It is also possible that a transient rise in cAMP within the oocyte 
could stimulate increased PDE3A activity. We recently found that cAMP 
levels in mouse oocytes from primed mice injected with an ovulatory 
dose of hCG were significantly elevated 1 h post-hCG (Chen and 
Downs, unpublished), well before meiosis was reinitiated. This 
observation is consistent with our study in which pulsing immature 
denuded mouse oocytes with high concentrations of cAMP produced a 
meiosis-inducing stimulus in inhibitor-containing medium (Chen et al, 
2009). Although PDE activity was not measured, the results support 
the possibility that the enzyme can be activated by high oocyte cAMP 
levels, since (1) cAMP falls rapidly thereafter in vivo prior to GVB and 
(2) AMP-activated protein kinase is activated in oocytes pulsed with 
cAMP in vitro (see section below). 
IV. AMP-Activated Protein Kinase and Meiotic 
Resumption 
It is generally accepted that negative regulation of meiotic 
maturation by cAMP occurs via stimulation of PKA; thus, it follows that 
increased PDE3A activity leads to a drop in oocyte cAMP levels and 
subsequent GVB principally through inactivation of PKA. However, PDE 
cleaves cAMP into 5′-AMP, a compound that has been largely ignored 
in oocyte physiology, presumed to be an inactive byproduct of the 
enzyme in oocytes. Yet 5′-AMP is an important regulator of a 
serine/threonine kinase termed AMP-activated protein kinase, or 
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AMPK, that has been implicated in the regulation of meiotic induction 
in mouse oocytes. 
AMPK is a member of the AMPK/SNF1 protein kinase family 
whose members can be found in a diverse array of organisms (eg, 
mammals, plants and yeast) and are typically activated in response to 
nutritional or environmental stress. AMPK controls the activity of 
important rate-limiting enzymes of carbohydrate and fat metabolism, 
acting as a type of “fuel gauge” in response to changes in cellular 
energy charge (Hardie et al, 2006). Thus, as a result of stresses that 
compromise cellular energy levels, AMPK becomes activated, and a 
principal function is to conserve energy by shutting down energy-
depleting pathways and activating energy-generating pathways (Fig. 
5A). These activities are controlled at the level of post-translational 
modification and also gene transcription (Hardie, 2003). 
 
Figure 5 AMPK in metabolism and oocyte maturation. A, general metabolic control. 
High levels of ATP suppress AMPK activity while elevated AMP has the opposite effect. 
Activation of AMPK (asterisk) suppresses anabolic pathways that consume ATP and 
stimulates catabolic pathways that generate ATP. B, proposed contribution of AMPK to 
meiotic resumption in the mouse oocyte. PKA can phosphorylate AMPK and maintain it 
in the inactive state. A number of different stimuli can activate AMPK, including stress, 
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AMP produced by cAMP degradation, conversion of AICAR to the AMP analog, ZMP, and 
upstream kinases such as LKB1 and CaMKKβ. Active AMPK phosphorylates, and 
inactivates, mitochondria-associated acetyl CoA carboxylase II. This enzyme catalyzes 
the conversion of acetyl CoA to malonyl CoA, an important negative regulator of fatty 
acid transport into the mitochondrion, and, thus, fatty acid oxidation. Since fatty acid 
oxidation appears to be a vital component of meiotic induction in mouse oocytes, the 
positive action of AMPK on oocyte maturation is likely due, at least in part, to 
activation of fatty acid oxidation (see Downs et al, 2009), 
AMPK is a heterotrimeric protein with a catalytic α subunit and β 
and γ regulatory subunits, and its activity is sensitively controlled 
within cells by the AMP/ATP ratio (reviewed by Sanz, 2009). Since the 
level of ATP in cells is in the millimolar range while that of AMP is much 
lower, small increases in AMP or larger decreases in ATP significantly 
increase the AMP/ATP ratio and bring about activation of the enzyme 
(Hardie et al, 1998). AMP activates AMPK allosterically but also by 
promoting phosphorylation of its catalytic α subunit at T172 by an 
upstream kinase and suppressing its inactivation by dephosphorylation 
(Hardie and Carling, 1997; Sanders et al, 2007). AMPKα can also be 
negatively regulated at S485/491 by elevated cAMP, presumably via 
PKA (Hurley et al, 2006), and suppressing AMPK activity could help 
mediate meiotic arrest brought about by high levels of cAMP in the 
oocyte. AMP does not accumulate appreciably in cells due to the 
activity of adenylate kinase, but it is possible that, after the 
gonadotropin surge, PDE activity within oocytes generates enough AMP 
from cAMP degradation to activate AMPK that, in turn, can provoke a 
positive stimulus for oocyte maturation. 
We have shown that both α1 and α2 isoforms of the catalytic 
subunit of AMPK are present in extracts from oocytes and oocyte-
cumulus cell complexes (Downs et al, 2002). Also, the AMPK activator, 
AICAR, is a potent stimulator of GVB, and this meiotic induction is 
associated with increased AMPK activity. AICAR is unable to reverse 
the inhibitory action of MPF inhibitors, indicating a site of action 
upstream of MPF. Subsequent studies have established that an 
increase in AMPK precedes GVB and is required for meiotic induction 
by AICAR (Chen et al, 2006), different stresses (LaRosa and Downs, 
2006, 2007) and the more physiological stimulators, FSH and 
amphiregulin (Chen et al, 2008); furthermore, specific AMPK inhibitors 
can prevent such meiotic induction. Interestingly, recent work from 
our lab shows that cAMP pulsing of the oocyte itself can also induce 
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maturation, in concert with activation of AMPK (Chen et al, 2009), 
supporting the idea that PDE-generated AMP can activate AMPK. AMPK 
may act by turning on fatty acid oxidation, which appears to be 
important for meiotic resumption in the mouse (Downs et al, 2009). 
Although the accumulated data support a role for AMPK in meiotic 
induction in the mouse, it remains to be determined if its participation 
is an absolute requirement. A potential scheme is presented in Fig. 5B 
that shows how AMPK might participate in meiotic resumption in 
mouse oocytes. 
Work from other labs suggests that the meiosis-inducing action 
of AMPK may be unique to the mouse. When cow and pig oocytes were 
treated with AMPK activators, meiotic maturation was suppressed 
instead of stimulated (Bilodeau-Geoseels et al, 2007; Mayes et al, 
2007; Tosca et al, 2007). In addition, work in progress in our lab 
comparing mouse and rat oocytes indicates profound differences in a 
number of meiotic behaviors, most notably a failure of rat oocyte 
AMPK to stimulate meiotic resumption and differences in localization of 
active AMPK throughout the maturation period from GVB to MII. 
The participation of AMPK in reproduction is an important 
consideration, especially considering its potential relationship with 
certain reproductive complications. A common treatment for both 
polycystic ovary syndrome and type II diabetes is metformin, a drug 
that has recently been shown to act through activation of AMPK (Zhou 
et al, 2001). Thus, it is possible that alterations in AMPK function can 
lead to reproductive anomalies and this kinase holds promise as a 
potential therapeutic target (eg, Ruderman and Prentki, 2004; Kahn et 
al, 2005; Viollet et al, 2009; Zhang et al, 2009). Indeed, recent use of 
a diabetic mouse model has shown that AMPK can ameliorate some of 
the symptoms of diabetes, including lesions in normal meiotic 
maturation (Ratchford et al, 2007). 
An additional regulatory role for AMPK that has recently been 
uncovered is that of mitotic cell polarity and division (Williams and 
Brenman, 2008) that has important implications for the malignant 
phenotype (Kuhajda, 2008; Jansen et al, 2009). Current work in 
progress in our lab shows that active AMPK localizes with condensed 
chromatin and the meiotic spindle throughout maturation; thus, it is 
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likely that this kinase plays an important role throughout the entire 
period of oocyte maturation, from meiotic resumption to MII. 
V. Concluding remarks 
The recent work on EGF-like peptides and cGMP serve to 
emphasize the complex and highly integrated nature of meiotic 
regulation. Carefully timed paracrine and gap junctional signaling 
between the mural and cumulus granulosa cells as well as between the 
somatic and germ cell compartments is essential for the successful 
control of oocyte development from early growth through terminal 
maturation prior to fertilization. This complexity is inherent in the 
challenge to those studying the process. 
Figure 1 incorporates results from recent studies into an 
integrated scheme for meiotic regulation in the mouse follicle. It is not 
meant to be all-inclusive, and emphasis is on those aspects for which a 
reasonable body of evidence exists in the litereature. Since not all 
potential chemical and pathway participants could be discussed in this 
review due to space constraints, this diagram should be viewed as a 
simplified version of reality. Certain aspects are speculative and 
remain to be proven, but with the rapid advances in molecular and 
technical tools in recent years, the rate of important new findings can 
only accelerate. Some important unanswered questions remain, 
including: (1) How are signal transduction pathways integrated 
between the somatic and germ cell compartments to communicate the 
meiosis-inducing signal? (2) To what extent are gap junction 
uncoupling and positive stimulation utilized to achieve meiotic 
resumption? (3) What is the chemical nature of the putative positive 
stimulus? and (4) What differences exist between species in meiotic 
regulation? 
It is becoming increasingly clear that what occurs 
mechanistically in one species is not necessarily duplicated in another. 
It is already known that significant differences exist between species in 
the sensitivity of oocytes to meiotic inhibitors, the timing of meiotic 
maturation, and even maturation status at the time of ovulation. While 
we know that LH is the initial upstream positive regulator of GVB, and 
MPF is the downstream meiotic trigger, the intermediate 
hormonal/metabolic/biochemical activity manifested in granulosa cells 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Molecular Reproduction and Development, Vol. 77, No. 7 (July 2010): pg. 566-585. DOI. This article is © Wiley and 
permission has been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission 
for this article to be further copied/distributed or hosted elsewhere without the express permission from Wiley. 
30 
 
and oocytes to reach that physiological endpoint may exhibit 
considerable variation between species. It therefore remains 
incumbent upon us to resist sweeping generalizations based on data 
from a limited number of species. Because of this, it is possible, if not 
likely, that no oocyte from a given species mimics completely the 
transduction systems implemented by another species. 
  
 
Figure 6 Model for meiotic regulation in the mouse. Shown are the three cell types 
within the follicle--mural and cumulus granulosa cells and the oocyte—and the 
interactions between them. Red lines depict inhibitory processes; green lines are 
stimulatory; and dotted lines represent agents that diffuse between cells. Active 
enzymes within the oocyte are denoted by an asterisk. In the oocyte, PGR3-dependent 
cAMP production activates PKA, which negatively regulates MPF. cGMP produced within 
the granulosa cells by soluble or membrane bound guanylate cyclase (GC) is 
transmitted through gap junctions to the oocyte where it suppresses PDE3 activity and 
helps to maintain meiotic arrest by sustaining high cAMP levels and PKA activity. 
Soluble GC can be stimulated by nitric oxide (NO), while membrane-bound GC can be 
stimulated by atrial natriuretic peptide (ANP). LH stimulation of the mural granulosa 
cells initiates a signal transduction cascade that results in p38MAPK-dependent 
production of EGF-like peptides (EGFp) that act in autocrine fashion to stimulate the 
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phosphorylation and activation of ERK1/2. ERK1/2 then drives the synthesis of 
prostaglandin E2 that diffuses to cumulus granulosa cells, binds to the prostaglandin 
receptor PTGER2 and triggers the synthesis of EGFp (see Shimada et al, 2006). FSH 
can mimic this action in cumulus cells. ERK1/2 terminates gap junction coupling 
between the two granulosa compartments and blocks cGMP transfer to the oocyte; it 
also generates a positive signal (X) for maturation that can be transmitted through 
gap junctions or possibly diffuses to the oocyte. PDE3 activity in the oocyte is 
increased via protein kinase B (Akt), the removal of cGMP inhibition, and perhaps also 
by a transient increase in oocyte cAMP and PKA activity that occurs following 
gonadotropin stimulation of the granulosa cells. The resulting decrease in cAMP levels 
leads to inactivation of PKA and elimination of its block to MPF activation. AMPK is 
activated in immature mouse oocytes in response to gonadotropin stimulation and 
helps drive MPF activation and GVB, most likely through indirect means. Its activation 
may result from AMP generated by PDE3 and/or perhaps by an upstream kinase 
(AMPKK), whose identity has not yet been identified. 
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